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Abstract
The aim of this study was to assess changes in salivary electrolyte flow and composition and the presence of 
anti-Ro/SSA and anti-La/SSB serum and saliva antibodies and their implications for the non-invasive diagnosis 
of SS. 
Study design: 73 patients were studied, divided into the following experimental groups: primary Sjögren syn-
drome (SSp) (n=15), secondary SS (SSs) (n=17), dry mouth, dry eye without Sjögren’s syndrome (BO) (n=20) 
and healthy controls (C) (n=21). We conducted a baseline assessment of salivary flow and saliva sampling for the 
measurement of sodium, chlorine, potassium, calcium and phosphate electrolytes, and the determination of anti-
Ro/SSA and La/SSB antibodies; a serum sampling was made to assess antibody positivity. 
Results: Salivary flow in SSp, SSs and BO was significantly lower (p<0.001) relative to C. The salivary composi-
tion of SS showed an increase of inorganic components. Anti-Ro/SSA and anti-La/SSB antibodies occurred more 
frequently in serum and saliva in SS patients compared with BO and C, with higher frequency of positivity in 
serum compared with saliva. 
Conclusion: Our results suggest new tools that could aid the non-traumatic diagnosis of the origin of hyposaliva-
tion.
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Introduction
One of the essential components for maintaining oral 
health is saliva, so the decline of its secretion is a major 
health problem of the oral tissues (1). It has been shown 
that saliva is able to control infections such as oral her-
pes thanks to its immunological function (2), and it is 
also involved in adequate swallowing, chewing, phona-
tion, perception of taste, and so on. (3). Xerostomia is 
one of the most common stomatological symptoms (4) 
and among its consequences are insomnia, irritability, 
depression and impaired quality of life for patients.  Dry 
mouth can be single or multi-factorial in origin, with 
hormonal changes, autoimmune diseases, drug intake, 
nutritional deficiencies, inflammatory processes, ad-
vanced age, etc. being involved in its appearance. (5). 
One of the most important causes of xerostomia is Sjö-
gren’s syndrome (SS), a chronic disorder that causes dry 
mucous membranes, mainly in mouth and eye, due to 
a connective tissue disorder with diminished or absent 
glandular secretions (6,7). Currently, one of the items 
that lead to accurate diagnosis of the disease is derived 
from biopsies of minor glands of the lip, which is an 
invasive technique (7). Sialochemistry methods could 
provide a diagnostic option of great clinical interest be-
cause these are not invasive, are low cost and may well 
serve as a means of early diagnosis.
The aim of this study was to analyze the rates of sali-
vary electrolytes and frequency of positive anti-Ro/SSA 
and La/SSB antibodies in patients with hyposalivation 
of different etiology, assessing their value as a method 
of early diagnosis of SS syndrome.
Material and Methods
Patients
 A total of 74 patients were analyzed, 32 with SS (15 
had primary SS (SSp) and 17 secondary SS (SSs) and 
20 with dry mouth and dry eye (BO), attended for the 
disease in the Rheumatology Unit of the Sanatorio Al-
lende between January 2005 and January 2007, average 
age 50 years (± 53 years), 86% of whom were women. 
The control group was composed of 22 healthy patients 
in the same age range as the cases that were seen in the 
same hospital. For the diagnosis of SS, the American-
European Consensus Group Criteria for Rheumatology 
(8) were used. Exclusion criteria were set as patients 
undergoing chemotherapy or radiation therapy to the 
craniofacial region, patients with tumors in the head 
and neck region, patients with psychiatric disorders, 
patients with metabolic disorders or drug intake, pa-
tients with Hepatitis C. Patients underwent a complete 
medical history and examination of the oral cavity. In 
all cases informed consent was obtained. The study was 
approved by the Ethics Committee of the Sanatorio Al-
lende (CLEIS), following the guidelines of the Interna-
tional Medical Association. 
Methods
In all patients, after rinsing with distilled water, base-
line saliva samples were collected for 10 minutes in 
the morning, fasting, and were weighed in a precision 
balance (Mettler), determining a flow value using the 
milligram equivalent formula at milliliter per minute, 
dividing this value by 10 and thereby obtaining the flow 
in milliliters per minute. The samples were stored at 
4°C. Biochemical analysis of the inorganic compounds 
sodium (Na+), chlorine (Cl-) and potassium (K) by 
flame photometry; calcium (Ca++) was performed 
by Henry’s direct colorimetric method, and of phos-
phate (PO2-) by Vanderline’s colorimetric technique. 
Venous blood collection was performed to determine 
anti-Ro/SSA and La/SSB antibodies, also assessed in 
saliva. The detection of these antibodies was made by 
a commercial enzyme immuno-assay (Orgentec from 
Germany). Plates were used that were previously im-
munized with SS-A and SS-B antigens. The samples 
were diluted 1:100 in Tris buffer, NaN3 (0.1% (w/w) 
and incubated with antigen. Subsequently, nonspecific 
serum components were removed by washing (PBS, 
NaN3 0.1% w/w). Human anti-IgG Ro and anti-IgA La 
antibodies were used conjugated with peroxidase; the 
measurement was performed in an ELISA reader. Sam-
ples from patients with optical density values higher 
than the standards were considered positive (the aver-
age of the optical densities of normal saliva + 2 stand-
ard deviations sets the ceiling value above which a sa-
liva problem is considered positive) (9).
Statistical Analysis
Statistical analysis was made using the Student’s T-test 
for independent data, determining a value of p<0.05 to 
consider a comparison as statistically significant. 
Results
Of the total of patients, 73 (86%) were women, with av-
erage age of 53 and mean disease evolution of 9 years.  
Salivary flow values were 0.36 ± 0.05 ml/min in the BO 
group, 0.22 ± 0.003 in SSp, 0.32 ± 0.05 in SSs and 1.04 
± 0.1 in group C. When comparing the groups studied, 
there was a significant decrease (p<0.001) of baseline 
flow in patients with BO, SSp and SSs in relation to 
group C. The SSp group presented a baseline flow val-
ue significantly lower (p<0.05) than SSs and BO. The 
average values of the electrolytes found in saliva with 
their statistical differences are shown in (Table 1). Ta-
ble 2 shows the percentage of cases positive for anti-Ro/
SSA and La/SSB antibodies in serum and saliva in the 
different experimental groups. 
When making statistical comparisons between the dif-
ferent study groups, according to positivity for anti-Ro/
SSA and La/SSB antibodies, measured in serum and 
saliva, highly significant differences were observed for 
the Ro antibody between patients with SSp or SSs and 
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the controls (p<0.0001). These differences were also 
observed for the antibody La (p<0.0001). 
Discussion
It is reasonable to believe that changes in salivary se-
cretion and changes in protein composition promote the 
growth of microorganisms associated with the condi-
tions most frequently found in the oral cavity (caries, 
gingivitis, mucosal infections) (10-12). Electrolytes 
are known to be secreted in the mouth by the salivary 
glands, although the exudation of serum from injured 
oral mucosa also contributes to electrolyte concentra-
tions found in saliva. In patients with SS, an increase 
has been documented in the rate of salivary albumin 
due to inflammation of the salivary glands and to the 
leakage of serum through mucous membranes easily 
damaged by mechanical action; this could equally be 
the mechanism that promotes salivary electrolyte ab-
normalities in SS (13,14).
In our control group, the concentration of electrolytes 
studied was within normal limits. In contrast, in the 
other groups of patients significant changes were ob-
served. Although previous studies (15) have docu-
mented a slight tendency to increased salivary concen-
trations of Na compared with the control group, in our 
study we documented only a slight increase, although 
significant in the comparison between SSs and controls, 
which could be due to a decrease in Na reabsorption 
in the salivary gland ducts. In relation to calcium, we 
observed a significantly higher concentration in all 
groups with hyposalivation compared with the control 
group. In our view, increased salivary Ca stems from 
a shift of plasma calcium through the injured mucosa. 
The plasma concentration of Ca is a plausible source 
of salivary Ca in damaged mucosa, as previously dem-
onstrated by Sewon et al. (14), who reported a positive 
correlation between gingival bleeding and Ca in saliva. 
In this study we have seen a very significant increase 
Table 1. Mean values (standard error) of each electrolyte studied. 
 (*) Indicates statistically significant differences between the control group (p<0.0001), and the other groups (**) Indicates 
statistically significant differences between the groups SSp, SSs and BO (p<0.0001); (***) indicates statistically significant 
differences between SSp and SSs (p<0.05). SSp: Primary Sjögren; SSs: Secondary Sjögren, BO: Dry mouth and eye; C: 
control.
Table 2. Percentage of samples positive for Ro and La antibodies in serum and 
saliva.
SSp: Primary Sjogren's Syndrome, SSs: Secondary Sjögren, BO: Dry Mouth and 
Eye C: control. 
Group CL
-
( mEq/ml) 
Na+
(mEq/ml)
Ca+2
(mg/dl)
K+
mEq /l) 
PO-2
(mg/dl)
SSp 37.1 ± 2.0 7.07 ± 0.5 5.04 ± 0.5 23.3 ± 2.0 9.90 ± 0.3 
SSs 77.2 ± 2.5(***) 9.8 ± 1.1(***) 4.35 ± 0.6(***) 33.8 ± 3.1(***) 24.9 ± 2.0(***)
BO 25.8 ± 2.1(**) 10.20 ± 1.7(**) 4.25 ± 0.5(**) 36.2 ± 2.8(**) 17.4 ± 1.4(**)
Control 15.6 ± 1.4(*) 8.3 ± 1.01(*) 2.60 ± 0.2(*) 18.8 ±  2.1(*) 14.5 ± 1.4(*) 
Source 
   Group 
SERUM SALIVA 
Ro/SSB
%
La/SSB
%
Ro/SSA
%
La/SSB
%
SSp
(n=17) 
78 70 55 46 
SSs 
(n=15) 
70 65 48 40 
BO
(n=21) 
10 5 0 0 
C
(n=20) 
0 0 0 0 
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in salivary levels of K in all the hyposalivation groups 
compared with controls. Plasma K has a concentration 
about five times higher than that of salivary K, and so 
mucosa altered by disorders accompanying hyposaliva-
tion could be the source of the increase in salivary K+. 
The possibility might also be considered of a defect re-
lated to mechanisms of ductal reabsorption in the SS, 
since we have observed increased levels of K+ in SSp 
compared to the BO group. With respect to phosphate 
concentration, the group presenting the highest rate was 
that of patients with SSs. However, we note that the lev-
els increase in SSp, which is discordant since it has been 
shown that phosphate concentration varies inversely 
with salivary flow rate (16,17). In all groups, differences 
were statistically significant in relation to controls. We 
did not find an explanation for observed statistical dif-
ferences in rates of salivary phosphates in SSp and SSs, 
as there was no explanatory evidence in the literature 
related to the topic. However, the deepening of research 
on the significance of salivary phosphate in patients 
with hyposalivation of different origins is important 
for the outstanding contribution of this electrolyte in 
remineralization as a buffer agent in situations of low 
salivary flow (18). In general our findings on the sali-
vary concentration of the electrolytes examined shows 
that the disorders are more pronounced in SSp and SSs 
compared with controls and the group BO. This could 
give some value to the determination of electrolytes in 
saliva as markers of SS.
In relation to the study of the profile of anti-Ro/SSA and 
La/SSB antibodies, a significant increase was seen in 
antibody positivity both in serum and in saliva in SSp 
and SSs compared with controls and with the group of 
patients with hyposalivation unrelated to SS. The de-
finitive diagnosis of SS is currently made by conducting 
a minor salivary gland biopsy in the lip (19). Our results 
thus point to new tools, both through the determination 
of electrolytes and of Ro/SSA and La/SSB antibod-
ies in saliva, which could help diagnose patients with 
hyposalivation and avoid invasive biopsy techniques. 
Larger studies are needed to allow further investigation 
of this matter. 
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